The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.

The researchers tracked nearly 175,000 patients with diabetes who received semaglutide - the active ingredient in Ozempic and other Novo products - and the same number of patients with diabetes ...

WE expect a lot from our breakfast – tasty, quick, on-the-go and cheap. So it’s no wonder that “healthy” often drops off the ...